The Supreme Court asked a drug manufacturer if medicine for the rare disease Spinal Muscular Atrophy (SMA) can be made available at a lower price in India. The Court said that the Union of India and Seba PA can contact companies making the drug. This would help ensure affordable treatment for patients. The aim is to reduce the financial burden on families dealing with SMA.
